Literature DB >> 19851866

Protective effects of acetyl-L-carnitine on cisplatin cytotoxicity and oxidative stress in neuroblastoma.

Zekiye Sultan Altun1, Dilek Güneş, Safiye Aktaş, Zübeyde Erbayraktar, Zübeyde Erbayrktar, Nur Olgun.   

Abstract

The most widely used platinum-derived drug is cisplatin in neuroblastoma (NB) chemotherapy, which is severely neurotoxic. Acetyl-L-Carnitine (ALC) is a natural occurring compound with a neuroprotective activity in several experimental paradigms. The aim of this study was to determine the effects of ALC on cisplatin induced cytotoxicity and oxidative stress in NB cells. SH-SY5Y (N-Myc negative) and KELLY (N-Myc positive) human NB cell lines were used. Cisplatin induced apoptosis was assessed by using a Cell Death Detection ELISA(PLUS) kit. Lipid peroxidation levels were determined by HPLC analysis. Glutathione levels were determined spectrophotometrically. ALC was used prophylactic or after cisplatin application. The level of cisplatin doses were determined in both type of NB cells at which 50% cell death occurred along with synchronized apoptosis induced. Prophylactic 10 and 50 micromol of ALC concentrations were decreased cisplatin induced lipid peroxidation compared to controls that normally exhibited apoptosis especially in SH-SY5Y cells. Cisplatin caused oxidative stress through decreasing glutathione levels in both cell types. ALC were effectively inhibited the increase in cisplatin induced oxidized glutathione and lipid peroxidation formation in NB cells. We suggested that prophylactic ALC would be a useful agent for cisplatin induced toxicity in NB cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19851866     DOI: 10.1007/s11064-009-0076-8

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  35 in total

1.  Anti-apoptotic effect of trans-resveratrol on paclitaxel-induced apoptosis in the human neuroblastoma SH-SY5Y cell line.

Authors:  G Nicolini; R Rigolio; M Miloso; A A Bertelli; G Tredici
Journal:  Neurosci Lett       Date:  2001-04-13       Impact factor: 3.046

2.  The effect of modulation of gamma-glutamyl transpeptidase and nitric oxide synthase activity on GSH homeostasis in HepG2 cells.

Authors:  Inga Kwiecień; Hanna Rokita; Elzbieta Lorenc-Koci; Maria Sokolowska; Lidia Włodek
Journal:  Fundam Clin Pharmacol       Date:  2007-02       Impact factor: 2.748

3.  Evidence that nerve growth factor promotes the recovery of peripheral neuropathy induced in mice by cisplatin: behavioral, structural and biochemical analysis.

Authors:  L Aloe; L Manni; F Properzi; S De Santis; M Fiore
Journal:  Auton Neurosci       Date:  2000-12-28       Impact factor: 3.145

4.  Effect of protective agents against cisplatin ototoxicity.

Authors:  L P Rybak; K Husain; C Morris; C Whitworth; S Somani
Journal:  Am J Otol       Date:  2000-07

5.  Cisplatin-induced DNA-platination in experimental dorsal root ganglia neuronopathy.

Authors:  C Meijer; E G de Vries; P Marmiroli; G Tredici; L Frattola; G Cavaletti
Journal:  Neurotoxicology       Date:  1999-12       Impact factor: 4.294

6.  Squalene selectively protects mouse bone marrow progenitors against cisplatin and carboplatin-induced cytotoxicity in vivo without protecting tumor growth.

Authors:  Bikul Das; Roula Antoon; Rika Tsuchida; Shamim Lotfi; Olena Morozova; Walid Farhat; David Malkin; Gideon Koren; Herman Yeger; Sylvain Baruchel
Journal:  Neoplasia       Date:  2008-10       Impact factor: 5.715

7.  Acetyl-L-carnitine corrects the altered peripheral nerve function of experimental diabetes.

Authors:  S Lowitt; J I Malone; A F Salem; J Korthals; S Benford
Journal:  Metabolism       Date:  1995-05       Impact factor: 8.694

8.  Retinoic acid differentiated SH-SY5Y human neuroblastoma cells: an in vitro model to assess drug neurotoxicity.

Authors:  G Nicolini; M Miloso; C Zoia; A Di Silvestro; G Cavaletti; G Tredici
Journal:  Anticancer Res       Date:  1998 Jul-Aug       Impact factor: 2.480

9.  Solution structure of a cisplatin-induced DNA interstrand cross-link.

Authors:  H Huang; L Zhu; B R Reid; G P Drobny; P B Hopkins
Journal:  Science       Date:  1995-12-15       Impact factor: 47.728

10.  Diabetic neuropathy in the rat: 1. Alcar augments the reduced levels and axoplasmic transport of substance P.

Authors:  A M Di Giulio; E Lesma; A Gorio
Journal:  J Neurosci Res       Date:  1995-02-15       Impact factor: 4.164

View more
  7 in total

1.  2-deoxy-D-glucose induces oxidative stress and cell killing in human neuroblastoma cells.

Authors:  Damon C Shutt; M Sue O'Dorisio; Nukhet Aykin-Burns; Douglas R Spitz
Journal:  Cancer Biol Ther       Date:  2010-06-26       Impact factor: 4.742

2.  Comparison of Cisplatin with Lipoplatin in Terms of Ototoxicity.

Authors:  Efe Serinan; Zekiye Altun; Safiye Aktaş; Emre Çeçen; Nur Olgun
Journal:  J Int Adv Otol       Date:  2018-08       Impact factor: 1.017

3.  Protective effect of acetyl-l-carnitine against cisplatin ototoxicity: role of apoptosis-related genes and pro-inflammatory cytokines.

Authors:  Z Altun; Y Olgun; P Ercetin; S Aktas; G Kirkim; B Serbetcioglu; N Olgun; E A Guneri
Journal:  Cell Prolif       Date:  2013-11-29       Impact factor: 6.831

4.  Role of carnitine in cancer chemotherapy-induced multiple organ toxicity.

Authors:  Mohamed M Sayed-Ahmed
Journal:  Saudi Pharm J       Date:  2010-08-05       Impact factor: 4.330

5.  In vitro and in vivo evaluation of etoposide - silk wafers for neuroblastoma treatment.

Authors:  Burcin Yavuz; Jasmine Zeki; Jeannine M Coburn; Naohiko Ikegaki; Daniel Levitin; David L Kaplan; Bill Chiu
Journal:  J Control Release       Date:  2018-07-03       Impact factor: 9.776

6.  CDK2 inhibitors as candidate therapeutics for cisplatin- and noise-induced hearing loss.

Authors:  Tal Teitz; Jie Fang; Asli N Goktug; Justine D Bonga; Shiyong Diao; Robert A Hazlitt; Luigi Iconaru; Marie Morfouace; Duane Currier; Yinmei Zhou; Robyn A Umans; Michael R Taylor; Cheng Cheng; Jaeki Min; Burgess Freeman; Junmin Peng; Martine F Roussel; Richard Kriwacki; R Kiplin Guy; Taosheng Chen; Jian Zuo
Journal:  J Exp Med       Date:  2018-03-07       Impact factor: 14.307

7.  Liu Jun Zi Tang-A Potential, Multi-Herbal Complementary Therapy for Chemotherapy-Induced Neurotoxicity.

Authors:  Chun-Tang Chiou; Kaw-Chen Wang; Ying-Chen Yang; Chuen-Lin Huang; Sien-Hung Yang; Yao-Haur Kuo; Nai-Kuei Huang
Journal:  Int J Mol Sci       Date:  2018-04-23       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.